Wolverine Trading’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$72.1K Sell
10,400
-16,900
-62% -$117K ﹤0.01% 5326
2025
Q2
$162K Buy
+27,300
New +$182K ﹤0.01% 4010
2024
Q2
Sell
-13,100
Closed -$101K 4938
2024
Q1
$101K Buy
+13,100
New +$105K ﹤0.01% 4052
2022
Q1
Sell
-10,600
Closed -$63K 6028
2021
Q4
$63K Sell
10,600
-5,500
-34% -$38.2K ﹤0.01% 5255
2021
Q3
$100K Buy
+16,100
New +$181K ﹤0.01% 5770
2018
Q4
Sell
-172,800
Closed -$1.07M 4996
2018
Q3
$1.07M Buy
+172,800
New +$781K ﹤0.01% 2287
2017
Q4
Sell
-99,100
Closed -$1.18M 5255
2017
Q3
$1.18M Buy
99,100
+28,200
+40% +$418K ﹤0.01% 1756
2017
Q2
$1.05M Buy
+70,900
New +$946K ﹤0.01% 1699

Other funds holding MDXG

Wolverine Trading's MDXG Position: Q2 2022 in Review

Wolverine Trading sold out of MiMedx Group (MDXG) in Q2 2022, closing a stake of 16,116 shares — an estimated $77K sold.

Wolverine Trading first reported a position in MDXG in Q2 2016 and held it in 8 quarters. The position peaked at $284K in Q3 2018. 153 funds tracked by Wall St. Rank hold MDXG as of Q2 2022.

  • Wolverine Trading reported no remaining MiMedx Group position as of Q2 2022 after selling out during the quarter.
  • Wolverine Trading sold 16,116 MiMedx Group shares in Q2 2022, an estimated $77K.
  • Wolverine Trading first reported a position in MiMedx Group in Q2 2016 and held it in 8 quarters.
  • Wolverine Trading's MiMedx Group position peaked at $284K in Q3 2018.
  • 153 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2022.

Based on Wolverine Trading's 13F filing for Q2 2022, filed 15 Aug 2022.